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INTRODUCTION 
Insitu gel forming polymeric formulations are drug 
delivery systems that are in sol or suspension form 
before administration in the body, once administered 
undergoes gelation insitu to form a gel. Insitu gel 
forming systems have been widely investigated as 
vehicles for sustained drug delivery. 1 
PRINCIPLE OF INSITU GEL 
Formulation of insitu gel system involves the use of 
gelling agent which can form a stable sol/suspension 
system to contain the dispersed drug and other 
excipients. The gelling of this sol/suspension system is to 
be achieved in gastric environment, triggered by ionic 
complexation due to change in pH. The formulation 
adopted is a gellan gum or sodium alginate solution 
containing calcium chloride and sodium citrate, which 
complexes the free Calcium ions and releases them only 
in the acidic enviorment of stomach. Gellan gum or 
sodium alginate acts as gelling agent and can produce 
textures in the final product that vary from hard, non 
elastic, brittle gels to fluid gels. 2 The free calcium ions 
gets entrapped in polymeric chains of gellan gum or 
sodium alginate thereby causing crosslinking of polymer 
chains to form matrix structure. This gelation involves 
the formation of double helical junction zones followed 
by re-aggregation of double helical segments to form a 
three dimensional network by complexation with cations 
and hydrogen bonding with water.3  
ADVANTAGES OF INSITU GEL 
1. Poor bioavailability problem of conventional 
ophthalmic solution can be       overcome by use of 
gel that are instilled as drops into eyes. 
2. It increases the contact time of drug at the site of 
maximum absorption. 
3. Reduced frequency of administeration. 
4. Reduced systemic absorption of drug drained 
through the nasolacrimal duct may result in some 
undesirable side effects. 
5. It provides advantages such as the delivery of drugs 
with narrow absorption windows in the small 
intestinal region. 
6. The GRDDS are advantageous for drugs absorbed 
through the stomach e.g. ferrous salts and for drugs 
meant for local action in the stomach and treatment 
of peptic ulcer disease e.g. antacids. 
SUITABLE DRUG CANDIDATES FOR INSITU 
GEL 
      1. Narrow absorption window in GI tract, e.g., 
riboflavin and levodopa  
      2. Primarily absorbed from stomach and upper part of 
GItract, e.g., cinnerazine. 
      3. Drugs that act locally in the stomach, e.g., antacids 
and misoprostol  
      4. Drugs that degrade in the colon, e.g. ranitidine HCl 
and metronidazole  
      5. Drugs that disturb normal colonic bacteria, e.g., 
amoxicillin trihydrate  
 
ABSTRACT 
 The purpose of writing this review on insitu gel was to complete the recent literature with special focus on insitu gelling 
system to increase the residence time of drug at the target site. Insitu gells are of particular interest for drugs that have very less 
half life and are readily dissolved. Recent developments of insitu gelling system are its use as vehicles for the delivery of drugs 
for both local treatment and systemic effects. The main interest in recent development of insitu gelling system has been shown 
in advantages of insitu polymeric delivery system such as ease of administration, reduced frequency of administration, 
improved patient compliance and comfort. This review summerises the studies to evaluate the performance and application of 
these systems. This review article is prepaired to discuss formulation factors used during development of insitu drug delivery 
system, relevant biodegrable polymers for sol-gel transition, characterization, evaluation parameter and commercial 
formulations of insitu polymeric system. 
Keywords: Residence time, systemic effects, patient compliance evaluation. 
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IDEAL CHARACTERISTICS OF POLYMERS 
 1. It should be biocompatible. 
 2. It should be capable of adherence to mucus. 
 3. It should have pseudo plastic behavior. 
 4. It should have good tolerance and optical activity. 
 5. I should influence the tear behavior. 
 6. The polymer should be capable of decrease the 
viscosity with increasing shear rate offering lowered 
viscosity during blinking and stability of tear film during    
fixation. 
POLYMERS USED IN INSITU GELLING SYSTEM 
1. Gellan gum:   It is anionic deacetylated exocellular 
polysaccharide secreated by Pseudomonas elodea. It has 
tendency of gelation which is temperature dependent or 
cation induced. The formulation consisted of gellan 
solution with calcium chloride and sodium citrate 
complex. When administered orally, the calcium ions are 
released in acidic environment of stomach leading to 
gelation of gellan thus forming a gel in situ. In situ 
gelling gellan formulation as vehicle for oral delivery of 
theophylline is reported. 4 
2. Xyloglucan:  Xyloglucan is a polysaccharide derived 
from tamarind seeds and is composed of a (1-4)-β-D-
glucan backbonechain, which has (1-6)-α-D xylose 
branches that are partially substituted by (1-2)-β-D-
galactoxylose. xyloglucan is partially degraded by β- 
galactosidase, the resultant product exhibits thermally 
reversible gelation by the lateral stacking of the rod like 
chains. The sol-gel transition temperature varies with the 
degree of galactose elimination. It forms thermally 
reversible gels on warming to body temperature. Its 
potential application in oral delivery exploits the 
proposed slow gelation time (several minutes) that would 
allow in-situ gelation in the stomach following the oral 
administration of chilled xyloglucan solution20. 
Xyloglucan gels have potentially been used for oral, 
intraperitoneal, ocular and rectal drug delivery.5 
3. Alginic acid: Alginic acid is a linear block copolymer 
polysaccharide consisting of β-D-mannuronic acid and α-
L-glucuronic acid residues joined by 1, 4-glycosidic 
linkages. The proportion of each block and the 
arrangement of blocks along the molecule vary 
depending on the algal source. Dilute aqueous solutions 
of alginates form firm gels on addition of di and trivalent 
metal ions by a cooperative process involving 
consecutive glucuronic residues in the α-Lglucuronic 
acid blocks of the alginate chain. Alginic acid can be 
chosen as a vehicle for ophthalmic formulations, since it 
exhibits favorable biological properties such as 
biodegradability and nontoxicity. A prolonged 
precorneal residence of formulations containing alginic 
acid was looked for, not only based on its ability to gel in 
the eye, but also because of its mucoadhesive properties.6 
4. Chitosan: Chitosan is a biodegradable, 
thermosensitive, polycationic polymer obtained by 
alkaline deacetylation of chitin, a natural component of 
shrimp and crab shell. Chitosan is a biocompatible pH 
dependent cationic polymer, which remains dissolved in 
aqueous solutions up to a pH of 6.226. Neutralization of 
chitosan aqueous solution to a pH exceeding 6.2 leads to 
the formation of a hydrated gel like precipitate. The pH 
gelling cationic polysaccharides solution are transformed 
into thermally sensitive pH dependent gel forming 
aqueous solutions, without any chemical modification or 
cross linking by addition of polyol salts bearing a single 
anionic head such as glycerol, sorbitol, fructose or 
glucose phosphate salts to chitosan aqueous solution.7 
5. Carbopol: Carbopol is a well known pH dependent 
polymer, which stays in solution form at acidic pH but 
forms a low viscosity gel at alkaline pH. HPMC is used 
in combination with carbopol to impart the viscosity to 
carbopol solution, while reducing the acidity of the 
solution. These come under the category of pH-induced 
in-situ precipitating polymeric systems. Based on this 
concept, the formulation and evaluation of an ophthalmic 
delivery system for indomethacin for the treatment of 
uveitis was carried out. A pH induced in-situ 
precipitating polymeric system (an aqueous solution of 
carbopol-HPMC system) was designed and developed by 
Ismail et al. for plasmid DNA delivery.
8
 
6. Pectin: Pectins are a family of polysaccharides, in 
which the polymer backbone mainly comprises α-(1-4) D 
galacturonic acid residues. Low methoxy pectins (degree 
of esterification <50%) readily form gels in aqueous 
solution in the presence of free calcium ions, which 
crosslink the galacturonic acid chains in a manner 
described by egg-box model. Although the gelation of 
pectin will occur in the presence of H + ions, a source of 
divalent ions, generally calcium ions is required to 
produce the gels that are suitable as vehicles for drug 
delivery. The main advantage of using pectin for these 
formulations is that it is water soluble, so organic 
solvents are not necessary in the formulation. Divalent 
cations present in the stomach, carry out the transition of 
pectin to gel state when it is administered orally. 
Calcium ions in the complexed form may be included in 
the formulation for the induction of pectin gelation. 
Sodium citrate may be added to the pectin solution to 
form a complex with most of calcium ions added in the 
formulation. By this means, the formulation may be 
maintained in a fluid state (sol), until the breakdown of 
the complex in the acidic environment of the stomach, 
where release of calcium ions causes gelation to occur. 
The quantities of calcium and citrate ions may be 
optimized to maintain the fluidity of the formulation 
before administration and resulting in gelation, when the 
formulation is administered in stomach. The potential of 
an orally administered in situ gelling pectin formulation 
for the sustained delivery of Paracetamol has been 
reported.9 
7. Pleuronics:  Poloxamers or pluronic (marketed by 
BASF Corporation) are the series of commercially 
available difunctional triblock copolymers of non-ionic 
nature. They comprise of a central block of relatively 
hydrophobic polypropylene oxide surrounded on both 
sides by the blocks of relatively hydrophilic poly 
ethylene oxide. Due to the PEO/PPO ration of 2:1, when 
these molecules are immersed into the aqueous solvents, 
they form micellar structures above critical micellar 
concentration. . Chemically they are Oxirane, methyl-, 
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polymer with oxirane or α-Hydro-ω- hydroxypoly 
(oxyethylene) a poly (oxypropylene) b poly 
(oxyethylene) a block copolymer. The pluronic triblock 
copolymers are available in various grades differing in 
molecular weights and physical forms.  Pluronic F-127 
was used as an in situ gel forming polymer together with 
mucoadhesive polymers such as Carbopol 934 and 
hydroxylpropylmethylcellulose to ensure long residence 
time at the application site. Controlled release of drug 
was achieved in-vitro indicating antimycotic efficacy of 
developed formulation for a longer period of time.  
SYNTHETIC POLYMERS 
Synthetic polymers are popular choice mainly for 
parenteral preparations. The trend in drug delivery 
technology has been towards biodegradable polymers, 
requiring no follow up surgical removal, once the drug 
supply is depleted. Aliphatic polyesters such as poly 
(lactic acid), poly (glycolic acid), poly (lactide- 
coglycolide), poly (decalactone), poly ε-caprolactone 
have been the subject of the most extensive recent 
investigations. Synthetic polymers are popular choice 
mainly for parenteral preparations. The trend in drug 
delivery technology has been towards biodegradable 
polymers, requiring no follow up surgical removal, once 
the drug supply is depleted. Aliphatic polyesters such as 
poly (lactic acid), poly (glycolic 
poly(lactidecoglycolide), poly (decalactone), poly ε-
caprolactone have been the subject of the most extensive 
recent investigations.10 
DIFFERENT APPROACHES FOR IN SITU GEL 
DRUG DELIVERY 
There are four broadly defined mechanisms used for 
triggering the in situ gel formation of biomaterials: 
1. Physiological stimuli (eg temperature and pH) 
2. Physical changes in biomaterials (eg diffusion of 
solvent and swelling) 
3. Chemical reactions (eg, enzymetic, chemical and 
photo initiated polymerization) 
INSITU GEL FORMATION BY PHYSIOLOGICAL 
STIMULI 
Temperature triggered system– Temperature-sensitive 
hydrogels are probably the most commonly studied class 
of environment-sensitive polymer systems in drug 
delivery research. The use of biomaterial whose 
transitions from sol-gel is triggered by increase in 
temperature is an attractive way to approach in-situ 
formation. The ideal critical temperature range for such 
system is ambient and physiologic temperature, such that 
clinical manipulation is faccilated and no external source 
of heat other than that of body is required for trigger 
gelation. A useful system should be tailorable to account 
for small differences in local temperature, such as might 
be encountered in appendages at the surface of skin or in 
the oral cavity. Three main strategies are exists in 
engineering of thermoresponsive sol-gel polymeric 
system. For convenience, temperature-sensitive 
hydrogels are classified into negatively thermosensitive, 
positively thermosensitive, and thermally reversible gels. 
Negative temperature-sensitive hydrogels have a lower 
critical solution temperature (LCST) and contract upon 
heating above the LCST. Polymers with low critical 
temperature (LCST) transition between ambient and 
physiologic temperature is used for this purpose. One of 
the most extensively investigated polymers that exhibit 
useful LCST transition is poly (Nisopropylacrylamide) 
(PNIPAAm). A positive temperature sensitive hydrogel 
has an upper critical solution temperature (UCST), such 
hydrogel contracts upon cooling below the UCST. 
Polymer networks of poly (acrylic acid) (PAA) and 
polyacrylamide (PAAm) or poly (acrylamide-co-butyl 
methacrylate) have positive temperature dependence of 
swelling. The most commonly used thermoreversible 
gels are these prepared from poly (ethylene oxide)-b-
poly (propylene oxide)-bpoly (ethylene oxide) 
(Pluronics®, Tetronics®, poloxamer.) Polymer solution 
is a free flowing liquid at ambient temperature and gels 
at body temperature.11  
pH triggered systems-   Another formation of in situ gel 
based on physiologic stimuli is formation of gel is 
induced by pH changes. All the pH-sensitive polymers 
contain pendant acidic or basic groups that either accept 
or release protons in response to changes in 
environmental pH .The polymers with a large number of 
ionizable groups are known as polyelectrolytes. Swelling 
of hydrogel increases as the external pH increases in the 
case of weakly acidic (anionic) groups, but decreases if 
polymer contains weakly basic (cationic) groups. The 
most of anionic pH-sensitive polymers are based on PAA 
(Carbopol®, carbomer) or its derivatives. Likewise 
polyvinylacetal diethylaminoacetate (AEA) solutions 
with a low viscosity at pH 4 form hydrogel at neutral pH 
condition43. Drug formulated in liquid solutions have 
several limitations, including limited bioavailability and 
propensity to be easily removed by tear fluid. Kumar and 
Himmelstein sought to minimize this factor and 
maximize this drug delivery by making a poly (acrylic 
acid) (PAA) solution that would be gel at pH 7.4.The 
author found that at concentrations high enough to cause 
gelation, however, the low pH of PAA solution would 
cause damage to surface of eye before being neutralized 
by the lacrimal fluid. This problem was solved by 
partially by combining PAA with HPMC, a viscous 
enhancing polymer, which resulted in pH responsive 
polymer mixtures that was sol at pH 4 and gel at pH 
7.444. Mixtures of poly (methacrylic acid) (PMA) and 
poly (ethylene glycol) (PEG) also has been used as a pH 
sensitive system to achieve gelation.12 
In situ formation based on physical mechanism 
Swelling  
In situ formation may also occur when material absorbs 
water from surrounding environment and expand to 
occur desired space. One such substance is myverol 18-
99 (glycerol mono-oleate), which is polar lipid that 
swells in water to form lyotropic liquid crystalline phase 
structures. It has some Bioadhesive properties and can be 
degraded in vivo by enzymatic action.13 
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Diffusion 
This method involves the diffusion of solvent from 
polymer solution into surrounding tissue and results in 
precipitation or solidification of polymer matrix. 
Nmethyl pyrrolidone (NMP) has been shown to be useful 
solvent for such system.14 
In situ formation based on chemical reactions 
Chemical reactions that results in situ gelation may 
involve precipitation of inorganic solids from 
supersaturated ionic solutions, enzymatic processes, and 
photo-initiated Processes. 
Ionic crosslinking 
Polymers may undergo phase transition in presence of 
various ions. Some of the polysaccharides fall into the 
class of ion-sensitive ones. . Gellan gum commercially 
available as Gelrite® is an anionic polysaccharide that 
undergoes in situ gelling in the presence of mono- and 
divalent cations, including Ca2+, Mg2+, K+ and Na+.. 
Gelation of the low-methoxy pectins can be caused by 
divalent cations, especially Ca2+. Likewise, alginic acid 
undergoes gelation in presence of divalent/polyvalent 
cations e. g. Ca2+ due to the interaction with glucuronic 
acid block in alginate chains.15 
Enzymatic cross-linking 
In situ formation catalysed by natural enzymes has not 
been investigated widely but seems to have some 
advantages over chemical and photochemical 
approaches. For example, an enzymatic process operates 
efficiently under physiologic conditions without need for 
potentially harmful chemicals such as monomers and 
initiators. Intelligent stimuli-responsive delivery systems 
using hydrogels that can release insulin have been 
investigated. Cationic pH-sensitive polymers containing 
immobilized insulin and glucose oxidase can swell in 
response to blood glucose level releasing the entrapped 
insulin in a pulsatile fashion. Adjusting the amount of 
enzyme also provides a convenient mechanism for 
controlling the rate of gel formation, which allows the 
mixtures to be injected before gel formation.16 
Photo-polymerisation 
Photo-polymerisation is commonly used for in situ 
formation of biomaterials. A solution of monomers or 
reactive macromer and initiator can be injected into a 
tissues site and the application of electromagnetic 
radiation used to form gel. Acrylate or similar 
polymerizable functional groups are typically used as the 
polymerizable groups on the individual monomers and 
macromers because they rapidly undergo photo-
polymerisation in the presence of suitable photo- 
initiator. Typically long wavelength ultraviolet and 
visible wavelengths are used. Short wavelength 
ultraviolet is not used often because it has limited 
penetration of tissue and biologically harmful. 
Photopolymerizable systems when introduced to the 
desired site via injection get photo cured in situ with the 
help of fiber optic cables and then release the drug for 
prolonged period of time. The photo-reactions provide 
rapid polymerization rates at physiological temperature. 
Furthermore, the systems are easily placed in complex 
shaped volumes leading to an implant formation. A 
photopolymerizable, biodegradable hydrogel as a tissue 
contacting material and controlled release carrier is 
reported by Sawhney.17-18  
APPLICABILITY OF IN SITU POLYMERIC 
DRUG DELIVERY SYSTEM 
1. Ocular drug delivery system 
In ocular delivery system natural polymers like gallan 
gum, alginic acid & xyloglucan are most commonly 
used. For local ophthalmic delivery system various 
compoundslike antimicrobial agent, anti-inflammatory 
agent & autonomic drugs are used to relieve intra ocular 
tension in glaucoma. Conventional delivery system often 
result in poor availability & therapeutic response because 
high tear fluid turn over & dynamics which cause rapid 
elimination of the drug from the eye so, the overcome the 
bioavailability problem ophthalmic in-situ gel was 
developed. To improve the bioavailability viscosity 
enhancers such as Hydroxy Propyl Methyl Cellulose, 
Carboxy Methyl Cellulose, Carbomers, Poly Vinyl 
alcohol used to increase the viscosity of formulation in 
order to prolong the precorneal residence time & 
improve the bioavailability, ease to manufacture. 
Penetration enhancer such as preservatives, chelating 
agent, surfactants are used to enhance corneal drug 
penetration.19 
2. Nasal drug delivery system 
In nasal in-situ gel system gallan gum & xanthan gum 
are used as in-situ gel forming polymers Momethasone 
furoatewas evaluated for it„s efficacy for the treatment of 
allergic rhinitis. Animal study were conducted using 
allergic rhinitis model & effect of in-situ gel on antigen 
induced nasal symptoms in sensitizes rats was observed. 
In-situ gel was found to inhibit the increase in nasal 
symptoms are compared to marketed preparation 
nosonex (Momethasone furoate suspension 0.05%). 
3. Rectal drug delivery system 
The rectal route may be used to deliver many types of 
drugs that are formulated as liquid, semisolid (ointments, 
creams and foams) and solid dosage forms 
(suppositories). 
Conventional suppositories often cause discomfort 
during insertion. In addition, suppositories are unable to 
be sufficiently retained at a specific position in the 
rectum, sometimes they can migrate up-wards to the 
colon that makes them possible for drug to undergo the 
first-pass effect. Choi et al. developed novel in situ 
gelling liquid suppositories with gelation temperature at 
30–36°C. Poloxamer 407 and/ or poloxamer 188 were 
used to confer the temperature-sensitive gelation 
property.In-situ gel possesses a potential application for 
rectal & vaginal route .Miyazaki et al. investigated the 
use of  
xyloglucan based thermo reversible gel for rectal drug 
delivery of Indomethacin. Administration of 
indomethacin loaded xyloglucan based system to rabbit 
indicated broad drug absorption & a longer drug 
residence time as compared to that resulting after 
administration of commercial suppository. For better 
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therapeutic efficacy &patient compliance, mucoadhesive, 
thermo sensitive, prolonged release vaginal gel 
incorporating Clotrimazole-β-cyclodextrin complex 
formulated for treatment of vaginitis.20 
4. Vaginal drug delivery system 
The vagina, in addition to being an important organ of 
reproductive tract, serves as a potential route for drug 
administration. Formulations based on a thermo-plastic 
graft copolymer that undergo in situ gelation have been 
developed to provide the prolonged release of active 
ingredients such as nonoxynol-9, progestins, estrogens, 
peptides and proteins62. Chang et al. have recently 
reported a mucoadhesive thermo-sensitive gel 
(combination of poloxamers and polycarbophil), which 
exhibited, increased and prolonged antifungal activity of 
clotrimazole in comparison with conventional PEG-
based formulation. 
5. Injectable drug delivery system  
One of the most obvious ways to provide sustained 
release medication is to place the drug in delivery system 
and inject or implant the system into the body tissue. 
Thermoreversible gels mainly prepared from poloxamers 
are predominantly used. The suitability of poloxamer gel 
alone or with the addition of 
hydroxypropylmethylcellulose (HPMC), sodium 
carboxymethylcellulose (CMC) or dextran was studied 
for epidural administration of drugs in vitro. The 
compact gel depot acted as the rate limiting step and 
significantly prolonged the dural permeation of drugs in 
comparison with control solutions. J. M. Barichello et al. 
evaluated Pluronic F127 gels, which contained either 
insulin or insulin-PLGA nanoparticles with conclusion, 
that these formulations could be useful for the 
preparation of a controlled delivery system. Likewise, 
poloxamer gels were tested for intramuscular and 
subcutaneous administration of human growth hormone 
or with the aim to develop a long acting single dose 
injection of lidocaine. g Injectable drug delivery system, 
cross linking of hydrazide modified by aluronic acid with 
aldehyde modified version of cellulose derivatives such 
as carboxy methyl cellulose, methyl cellulose, hydroxy 
propyl methyl cellulose are used. These in-situ forming 
gel were used for preventing postoperative peritoneal 
adhesion thus avoiding pelvic pain, bowel obstruction & 
infertility. For a better therapeutic efficacy & patient 
compliance, mucoadhesive, thermo sensitive, prolonged 
release vaginal gel incorporating Clotrimazole-β-
cyclodextrin complex was formulated for treatment of 
virginities.21 
6. Dermal and transdermal drug delivery system 
Thermally reversible gel of Pluronic F127 was evaluated 
as vehicle for the percutaneous administration of 
Indomethacin. In-vivo studies suggest that 20% w/w 
aqueous gel may be of practical use as a base for topical 
administration of the drug. Poloxamer 407 gel was found 
suitable for transdermal delivery of insulin73. The 
combination of chemical enhancers and iontophoresis 
resulted in synergistic enhancement of insulin 
permeation. 
7. Oral drug delivery system 
For the oral in situ gel delivery system pectin, 
xyloglucan & gellan gum natural polymers are used. 
Pectin formulation for sustained delivery of paracetamol 
has been reported. Advantages of pectin is water soluble 
so, no need to add organic solvent. Cross-linked dextran 
hydrogels with a faster swelling under high pH 
conditions, likewise other polysaccharides such as amide 
pectins, guar gum and insulin were investigated in order 
to develop a potential colon-specific drug delivery 
system. W. Kubo et al. developed the formulations of 
gellan and sodium alginate both containing complexed 
calcium ions that undergo gelation by releasing of these 
ions in the acidic environment of the stomach. Oral 
delivery of paracetamol was studied. Hydrogels made of 
varying proportions of PAA derivatives and crosslinked 
PEG allowed preparing silicone microspheres, which 
released prednisolone in the gastric medium or showed 
gastroprotective property.22 
EVALUATION AND CHARACTERIZATION OF 
IN SITU GELLING SYSTEM 
1. Clarity 
The clarity of formulated solution is determined by 
visual inspection under black & white Background. 
2. Texture analysis 
The consistency, firmness &cohesiveness of in situ gel 
are assessed by using texture profile analyzer which 
mainly indicated gel strength & easiness in 
administration in vivo higher value of adhesiveness of 
gel are needed to maintain an intimate contact with 
mucus surface. 
3. pH of gel 
pH can be determined formulation is taken in beaker & 
1ml NaOH added drop wise with continuous stirring. pH 
is checked by using pH meter. 
4. Sol-Gel transition temperature and gelling time 
For in situ gel forming systems incorporating 
thermoreversible polymers, the sol-gel transition 
temperature may be defined as that temperature at which 
the phase transition of sol meniscus is first noted when 
kept in a sample tube at a specific temperature and then 
heated at a specified rate. Gel formation is indicated by a 
lack of movement of meniscus on tilting the tube. 
Gelling time is the time for first detection of gelation as 
defined above. 
5. Gel-Strength 
This parameter can be evaluated using a rheometer. 
Depending on the mechanism of the gelling of gelling 
agent used, a specified amount of gel is prepared in a 
beaker, from the sol form. This gel containing beaker is 
raised at a certain rate, so pushing a probe slowly 
through the gel. The changes in the load on the probe can 
be measured as a function of depth of immersion of the 
probe below the gel surface. 
6. Gelling capacity 
In-situ gel is mix with simulated tear fluid (in the 
proportion of 25:7 i.e. application volume 25μl & normal 
volume of tear fluid in eye is 7μl) to find out gelling 
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capacity of ophthalmic product. The gelation assessed 
visually by noting the time for & time taken for 
dissolution of the formed gel.  
7. Rheological studies 
The viscosity measured by using Brookfield viscometer, 
cone & plate viscometer. In-situ gel formulation is 
placed in sample tube. Formulation should have viscosity 
5-1000mPas, before gelling & after ion gel activation by 
eye will have viscosity of from about 50-50,000 mPas. 
8. Isotonicity evaluation 
Isotonicity is important characteristics of ophthalmic 
preparation. Isotonicity is maintained to prevent tissue 
damage or irritation of eye. All ophthalmic preparation 
are subjected to isotonicity testing, science they 
exhibited good release characteristics & gelling capacity 
& the requite velocity. Formulation mixed with few 
drops of blood & observed under microscope at 45x 
magnification & compared with standard marketed 
ophthalmic formulation. 
9. Swelling studies 
Swelling studies are conducted with a cell, equipped with 
thermo jacket to maintain a constant temperature .The 
cell contains artificial tear fluid (composition – 0.67g 
Nacl, 0.20g NaHCo3, 0.008g Cacl2.2H2o & distilled 
water q.s to 100g)80. swelling medium equilibrating at 
370c one milliliter of formulated solution is placed in 
dialysis bag & put into the swelling medium. At specific 
time interval the bag is removed from the medium & 
weight is recorded. The swelling of the polymer gel as a 
function of time is determined by using the following 
relationship. 
% St = (Wt – W0) 100/W0 
   St = Swelling at time„t‟. 
   W0=Initial weight of gelling solution. 
   Wt=Final weight of gel. 
10. Statistical analysis 
Analysis of variance (ANOVA) is used the testing the 
difference between calculated parameters using SPSS 
statistical package. Statistical difference yielding P≤0.05 
is considered. Duncan multiple comparison is applied 
when necessary to identify which of the individual 
formulations are significantly different. 
11. High performance liquid chromatography 
The HPLC system is used in reversed phase mode. 
Analysis is performed on a Nova pack C18 packed 
column (150 mm length X 3.9 mm i.d). 
12. Fourier transformer infra red 
The possibility of drug excipient interaction is 
investigated by FTIR studies. The FTIR graph of pure 
drug & combination of drug with excipient are recorded 
by using KBR pellets. 
13. Thermal analysis 
Thermo gravimetric analysis can be conducted for in situ 
forming polymeric system to quantitative the percentage 
of water in hydrogel. Different scanning calorimetry is 
used to observed, if there are many changes in 
thermograms as compared with pure ingredients used 
thus indicating the interaction.  
14. In vitro drug release studies 
In vitro release study of in situ gel solution is carried out 
by using Franz diffusion cell. The formulation is placed 
in donor compartment & freshly prepared simulated tear 
fluid in receptor compartment. Between receptor & 
donor compartment dialysis membrane is placed (0.22 
μm pore size). The whole assembly is placed on 
thermostatically controlled magnetic stirrer. The 
temperature of the medium is maintained at 37ºc± 0.5ºc.  
1ml sample is withdrawn at predetermined time interval 
of 1hr for 6hrs the sample volume of fresh medium is 
replaced. The withdrawn sample is diluted to 10ml in 
volumetric flask with respective solvent & analyzed by 
UV spectrophotometer at respective nm using reagent 
blank. The drug content calculated using an equation 
generated from standard calibration curve. The 
percentage cumulative drug release (% CDR) calculated. 
The obtained data is further subjected to curve fitting for 
drug release data. The best fit model is checked for 
Krosmeyers peppas & Fickinian diffusion mechanism of 
their kinetics. 
15. Ocular irritancy studies 
Ocular irritancy studies are performed on male albino 
rabbits, weighing 1-2 kg. The modified Draize technique 
is used for ocular irritation potential of ophthalmic 
products. The formulation is placed in lower cul-de-sac 
& irritancy is tested at time interval of 1hr, 2hrs, 48hrs, 
72hrs, & 1 week after administration. The rabbits are 
observed periodically for redness, swelling, & watering 
of eyes. 
16. Sterility testing 
Sterility testing is carried out as per the IP 1996. The 
formulation is incubating for not less than 14 days at 
300-350c in the fluid thioglycolate medium to find the 
growth of bacteria & at 200-250 c in Soya bean casein 
digest medium to find the growth of fungi in 
formulation. 
17. Accelerated stability studies 
Formulation is replaced in amber colored vials & sealed 
with aluminum foil for the short term accelerated 
stability study at 40± 20 c & 75 ±5% RH as per 
International Conference of Harmonization (ICH) State 
Guidelines. Sample is analyzed at every month for 
clarity, pH, gelling capacity, drug content, rheological 
evaluation & in vitro dissolution.  
18. Histopathological studies 
Two mucosa tissue pieces (3 cm2) were mounted on in 
vitro diffusion cells. One mucosa was used as control 
(0.6 mL water) and the other was processed with 0.6 mL 
of optimized organogel (conditions similar to in vitro 
diffusion). The mucosa tissues were fixed in 10% neutral 
carbonate formalin (24 hours), and the vertical sections 
were dehydrated using graded solutions of ethanol. The 
subdivided tissues were stained with hematoxylin and 
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eosin. The sections under microscope were photographed 
at original magnification ×100. The microscopic 
observations indicate that the organogel has no 
significant effect on the microscopic structure of the 
mucosa. The surface epithelium lining and the granular 
cellular structure of the nasal mucosa were totally intact. 
No major changes in the ultrastructure of mucosa 
morphology could be seen and the epithelial cells 
appeared mostly unchanged. 
19. Antimicrobial activity  
Antimicrobial efficacy studies are carried out to ascertain 
the biological activity of sol-gel-system against 
microorganisms. This is determined in agar diffusion 
medium employing cup plate techniques. The microbial 
growth of bacteria is measured by conc of 
Standard preparation of antibiotic and carried out the 
microbial assay serial dilution method is employed.23 
RECENT ADVANCEMENTS 
One of the challenges facing todays pharmaceutical 
industry centreson coming up with efficient treatment 
options that are readily acceptable to physicians and 
patients. Delivery systems must also contribute to a 
better therapeutic outcome if they are going to provide 
viable alternatives to pharmaceuticals currently delivered 
by other routes. In situ gel formulations are one of the 
challenging drug delivery systems. Various biodegrable 
polymers are used for formulation of insitu gels, but 
there are fabrication problems, difficult process ability, 
and use of organic solvents for their preparation 
(especially for synthetic polymer based systems), burst 
effect and irreproducible drug release kinetics. Natural 
polymers satisfy the characteristics of an ideal polymer 
but batch to batch reproducibility is difficult therefore 
synthetic polymers are used. The recent advancement of 
biotechnologies has lead to the development of liable 
macromolecular therapeutic agents that require complex 
formulations for their efficient administration N-stearoyl 
L-alanine(m) ethyl esters when mixed with a vegetable 
oil and biocompatible hydrophilic solvent led to the 
formation of injectable, insitu forming organ gel. 
Following subcutaneous injection, leuprolide-loaded 
organ gel degraded and gradually released leuprolide for 
14 to 25d. 
The gastroretentive drug delivery system of famotidine 
was prepared, by employing two different grades of 
methocel K 100 and K15 M by effervescent technique; 
these grades of methocel were evaluated for their gel 
forming properties. Sodium bicarbonate was 
incorporated as a gas generating agent. The floating 
tablets were evaluated for uniformity of weight, 
hardness, friability, drug content, invitro buoyancy and 
dissolution studies. 24 
The gastro retentive controlled release drug delivery 
system of verapamil Hcl was prepared in an effort to 
increase the gatric residence time of the dosage form and 
to control the drug release. Hydroxypropyl methyl 
cellulose, carbopol and xanthan gum were incorporated 
for gel forming properties. Buoyancy was achieved by 
adding an effervescent mixture of sodium bicarbonate 
and anhydrous citric acid. Invitro release studies were 
performed and drug release kinetics was evaluated by the 
linear regression method. Optimized intragastric floating 
tablet showed no significant change in physical 
appearance, drug content after storage at 75% relative 
humidity for 3 months. 
Formulation, evaluation and optimization of stomach 
specific in situ gel of clarithromycin and metronidazole 
benzoate was studied by using sodium alginate as 
polymer and calcium carbonate was used as a cross 
linking agent .This study reported that oral 
administration of aqueous solutions containing sodium  
alginate resulted in formation of In situ gel ,such 
formulations are homogenous liquid when administered 
orally and become gel at contact site .stability study of 
check point batch after three month showed no change in 
in-vitro drug release profile, % assay and evaluation 
parameters .it was concluded that by adopting a systemic 
formulation approach ,an optimum point could be 
reached in the shortest time with minimum effort.25 
Novel Floating In situ Gelling System of Levofloxacin 
Hemihydrate was developed and evaluated by using 
varying concentrations of gellan gum and sodium 
alginate in deionized water containing sodium citrate. a 
stomach specific in situ gel of levofloxacin hemihydrate 
could be prepared using floating mechanism to increase 
the residence time of the drug in stomach and thereby 
increasing the absorption. This study shows the 
feasibility of in vitro gel forming from aqueous solution 
of sodium alginate and gellan gum containing Calcium 
ions in a complex form. it is concluded that levofloxacin 
hemihydrate could be targeted to stomach and be 
released slowly over a period of time. 
Ganapati rohith et al studied Floating drug delivery of a 
locally acting H2-antagonist An approach using an in 
situ gelling liquid formulation by using sodium alginate 
and calcium carbonate .By observing various evaluation 
parameters for the studied formulations, it can be stated 
that incorporation of sodium citrate and calcium chloride 
in the formulation is required to control and sustained the 
drug release from in situ gel. 
Formulation and Evaluation of Floating Oral In Situ 
Gelling System of Amoxicillin was done by using 
sodium alginate, calcium chloride, sodium citrate 
,HPMC K100, and sodium bicarbonate from which 
concluded that the floating in situ gel system of 
amoxicillin with increase gastric residence time can be 
formulated using sodium alginate as a gelling polymer 
and HPMC K100 as a thickening agent the prepared 
formulation can provide a site specific delivery of 
amoxicillin with zero order release kinetics.26  A method 
for producing in situ gelation of poloxamer and 
mucoadhesive polymer chitosan was developed  by 
utilizing the property of poloxamer solution to convert in 
to gel at physiological temperatures and of chitosan to 
undergo ion responsive gelation in presence of Sodium 
tripolyphosphate. Differential scanning calorimetry and 
tube inversion techniques were used to study 
micellization and gelation of the poloxamer 407 in 
presence of chitosan. Mixture of poloxamer and 
tripolyphosphate was found to reduce the critical 
micellization temperature and critical gelation 
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temperature of poloxamer solution in water. Poloxamer 
gel, so formed in situ, after the addition of chitosan and 
tripolyphosphate had shown decline in the dissolution 
rate and release characteristics of metoprolol, 
doxycycline and flufenamic acid. In addition to that, 
variation in the composition of both polymer components 
and tripolyphosphate had also shown the possibility to 
control the pH of system so that, it would enhance the 
solubility profile of drug.  
A hydrogel was developed which had shown the 
promising results in the spinal cord injury,when injected 
through 40 ìm needle in the solution phase, which 
converted in to gel inside the target tissue. Formulation 
was prepared by polycondensation, using two FDA 
approved polymer viz. Polyacrylic acid (Carbomer 947P) 
and Agarose, a common polysaccharide. Solution was 
injected in spinal cord of mouse and in situ gel formation 
was confirmed by magnetic resonance imaging that 
showed the presence of polymeric network at injection 
site. Hydrogel, so produced, had provided enough data to 
be considered as a new biocompatible tool that can be 
used as a local reservoir for in situ delivery of drugs.  
The textural characteristics like syneresis, opacity and 
fracture characteristics of gellan, agar and their mixed 
gels were studied on application of uniaxial compression. 
Increase in the concentration of colloids had shown to 
improve the opacity but reduces the syneresis. Syneresis 
was found to be at lower side, as 1.5% for mixed gel 
having 2% each of gellan and agar while opacity was 
found to be 30%, with even more values for opacity for 
the agar gel. Stress and energy for compression had 
improved the level of gelling agents. 
Formulation of pH sensitive hydrogels by morpholine 
derivatives was done by utilizing homopolymers and 
copolymers of N-ethylmorpholine methacrylamide and 
N, N-dimethylacrylamide applied in the form of matrices 
for ibuprofen release, which prevent the damage of 
mucous membrane due to drug. Hydrogel so formed 
were studied for the release rate at temperature 37 C and 
different pH values 2, 5 and 7 respectively. Dissolution 
of the ibuprofen from different formulation at different 
pH was studied. Results had shown that hydrogel were 
able to prevent crystallization of the ibuprofen at all pH.  
A pH sensitive insitu hydrogel based on the macro 
monomer synthesized by heat initiated free radical 
polymerization of methoxy poly(ethylene glycol)-
poly(caprolactone)-acryloyl chloride, poly(ethylene 
glycol)-methyl ether methacrylate and methacrylic acid. 
Macro monomer and hydrogels were characterized by 
utilizing NMR and FT-IR techniques. Other profile for 
the macro monomer produced was also studied like 
morphology, swelling behavior, in vitro drug release etc 
and toxicity profile of the macro monomer. Hydrogel 
that showed the sharp changes in the different pH values 
were selected as most promising candidate for oral drug 
delivery of dexamethasone in the inflammatory bowel 
disease. 27 
Examination of the cytocompatibility of amphiphilic, 
thermoresponsive and chemically cross linkable 
macromer forming an in situ hydrogel was done, via in 
vitro studies. Macromers were synthesized by 
pentaerythritol diacrylate monostearate, N-iso 
propylacrylamide, acrylamide and hydroxyethyl acrylate 
using different molar ratios and changing molecular 
weights. The lower critical solution temperature was 
evaluated to determine the cytocompatibility with the 
fibroblast cell of rat. Cell viabilities of over 80, were 
observed after the incubation of cell for 24 hour, with 
molecular weight in range 1500-3000 daltons. Chemical 
modification of the macromers had also shown the time 
and dose dependent effect on cell viability. The data 
obtained had depicted that chemically modified 
macromers form a less cytotoxic physical gel, while 
phase separation increased the cytotoxicity.  
A thermoresponsive and bioadhesive, in situ gelling 
system of drug delivery was formulated for treatment of 
esophageal pain and inflammation. Bioadhesive polymer 
used was Metolose, a cellulose derivative with 
thermoresponsive property. Thermal gelation 
temperature for the polymer was around 65-66 C. 
Alteration of pH between 2 to 10 and presence of 
alcohols had not influenced the gelation temperature but 
using water soluble salts and changing the concentration 
of polymer in solution (2-3%w/w) thermal gelation point 
can be reduced. Effect on the thermal gelation point, in 
vitro liberation and penetration was studied. Study 
showed that thermal gelation point did not vary but 
liberation and penetration of drug was changed. 
Morphological studies of esophagus had also shown that 
the system did no have any irritant effect or tissue 
damage effect on esophageal mucosa on exposure even 
after 12 hour. 
The evaluation of the gelation and release characteristics 
of different formulation was done containing release 
characteristics of physical mixtures of varying derivative 
pectin which was methoxylated to different 
concentration of xyloglucan and pectin where xyloglucan 
degree, i.e. high (31%) and low (9%) over a wide range 
of had the thermally reversible gelation and pectin had 
the pH varying from 1.2 to 5.0. A source of calcium in 
ion responsive gelation properties, in order to formulate 
complexed form was also added which released the 
Calcium in situ gelling vehicle for sustained drug 
delivery via oral route. Rheological studies showed that 
inclusion of pectin (0.75% w/w) had increase the gel 
strength of the 1.5% and 2.0% w/w xyloglucan and the 
resulting formulation produced. Plasma concentration 
studies in rats on oral administration the formulation had 
also shown the more sustained release and improved 
drug bioavailability was achieved by gel formed due to 
in situ gelation of this formulation, while the pectin 
(0.75%w/w) and xyloglucan(1.75%w/w) did not form 
any gel, under these condition. Visual observation of the 
gastric content of rat had shown that inclusion of pectin 
with xyloglucan had also reduced the erosion of gel 
formed  
Formulation a floating in situ gelling system of 
clarithromycin was done using gellan gum as gelling 
polymer and calcium carbonate as gas generating 
floating agent. In situ gelling system was prepared by 
dissolving different concentration of the gellan gum in 
water and uniformly dispersing the sucralfate. 
Formulation variable especially, gellan gum and 
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sucralfate had shown significant effect on the in vitro 
release of drug. The resultant in situ gelling system in 
comparison to amoxicillin suspension had shown 
improved efficacy towards the clearance of the H. pylori. 
Prolonged gastric residence time, because of floating, 
had also shown to have improved efficacy of the drug 
towards peptic ulcer treatment.  
Formulation of an intra gastric floating in situ gel system 
was done for controlled amoxicillin delivery in treatment 
of peptic ulcer disease caused by Helicobacter pylori (H. 
pylori). The system was prepared by, using different 
concentration of gellan gum in water containing citrate 
salt, to which varying drug and calcium carbonate (gas 
forming agent) was added. It had been shown, that 
concentration of calcium carbonate and gellan gum had 
significantly affected in vitro drug release. H. pylori 
clearance efficacy of the in situ gel forming system in 
reference to amoxicillin suspension had shown 
significant anti H. pylori effect when studied by 
polymerase chain reaction technique and microbial 
culture method. The results had also shown that in situ 
gel forming system of amoxicillin was more effective 
than the suspension due the prolonged gastro-retentive 
residence time. 
Comparision of the gelation and drug release 
characteristics of different formulation containing 
derivatized pectin was done which was methoxylated to 
different degree, i.e. high (31%) and low (9%) over a 
wide range of pH varying from 1.2 to 5.0. A source of 
calcium in complex form was also added which released 
the Calcium on breaking under the acidic conditions. In 
presence of Ca ions dilute pectin solution (1.5%w/w) 
undergo gelation due to cross linking of the galacturonic 
chain, at lower pH, but the gelating tendency of the 
pectin was reduced at the higher pH due to lack of Ca 
ions released from complex. Gelation property of the 
formulation prepared by pectin with 9% degree of 
esterification was examined in presence of Ca (1.6mM) 
over pH range of 2.5 to 5.0 and compared to the pectin 
with 31% degree of esterification. Pectin with low degree 
of esterification was found to produce the better gelation 
in comparison to pectin with high degree of gelation. A 
sustained delivery of the ambroxol was also shown by 
the formulation containing with Pectin low degree of 
esterification in gastric acidity controlled rabbits at pH 
5.5-5.7 and in situ gelation was confirmed by visual 
examination. So, Pectin with low degree of esterification 
had shown to be a potential candidate for producing in 
situ gelling system for sustained delivery of drugs at 
gastric pH.  
The effect of the varying gastric pH over a pH range of 
1-3 was done on gelation of the liquid formulation of 
pectin and in vitro and in vivo release of the paracetamol 
and ambroxol was studied from the resultant gels. 
Formulation was comprised of pectin with complexed Ca 
in aqueous medium. When such 2+ complex came in the 
acidic medium Ca were released 2+ which convert 
solution of pectin to gel. Gel (pectin 1-2%) suitable for 
the sustained delivery of paracetamol and ambroxol was 
formed at pH< 3 in vitro. While, very weak gels were 
produced at pH 3.0, leading to poor sustained release 
characteristics, in comparison to those, formed at pH 1.2, 
but no gelation at pH 3.5 was seen. Bioavailability for 
paracetamol and ambroxol from in situ formed gels were 
studied in gastric acidity controlled rabbits and visual 
observation for in situ gelation showed better gelation at 
both high and low gastric pH. Bioavailabilities for both 
drugs were found same for gels formed at low as well as 
high pH.  
The chitosan-glyceryl monostearate based in situ gelling 
system was prerared to produce sustained drug delivery 
and site specific targeting. The system was prepared by 
using 3%w/v chitosan and 3% w/v glyceryl monostearate 
in 0.33M citric acid solution. Formation of in situ gel 
was performed at biological pH and in vitro release for 
drugs was performed in Sorenson‟s phosphate buffer (pH 
7.4). Gelation of the system was characterized by 
studying effect of cross linker, determination of diffusion 
coefficient and water uptake by thermogravimetric 
analysis (TGA). Mucoadhesive property of gel was also 
studied using EZ tester. Studies showed that cross linker 
had result in the decrease of the rate and extent of the 
drug release. Glyceryl monostearate had enhanced 
mucoadhesive property of chitosan to a great extent. This 
in situ gel system on the basis of study had been reported 
suitable for both oral as well as parentral sustained 
delivery of drugs.  
Evaluation of the sustained delivery of paracetamol  was 
done via two in situ gel forming formulations. 
Formulation was basically consists of aqueous solution 
of gellan gum (1.0% w/v) or sodium alginate (1.5%w/v) 
containing the calcium ion complex, which in acidic 
environment causes release of calcium ions. These 
calcium ions then caused the gelation of the gelling 
agents (gellan gum or sodium alginate). In vitro studies 
had demonstrated diffusion controlled release of 
paracetamol from in situ formed gels over a period of 6 
hour. Bioavailability of paracetamol for in situ gel 
formulated was found to be similar to commercially 
available suspension of paracetamol.  
The gelling property for oral delivery of the cimetidine 
was evaluated. Formulations prepared were dilute 
solution of the enzyme treated xyloglucan which form 
thermosensitive gel on body temperature along with 
gellan gum and sodium alginate. Complexed calcium 
ions were also added which on release in the acidic 
environment form gel on contact with the polymers 
gellan gum and sodium alginate. In vitro study for 
cimetidine release was conducted over a period of 6 
hour. Plasma levels of cimetidine after oral 
administration to rabbits were compared with 
commercially available cimetidine/alginate suspension 
and in vivo release characteristics were found to be 
identical with commercial preparation. 
COMMERCIAL FORMULATIONS OF IN-SITU 
POLYMERIC SYSTEMS AT A GLANCE 
Regel: depot-technology:  
Regel is one of the Macromed's proprietary drug delivery 
system and based on triblock copolymer, composed of 
poly (lactide-co-glycolide)-poly (ethylene glycol)-poly 
(lactide-co-glycolide). It is a family of thermally 
reversible gelling polymers developed for parenteral 
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delivery that offers a range of gelation temperature, 
degradation rates and release characteristics as a function 
of molecular weight, degree of hydrophobicity and 
polymer concentration. Following injection, the physical 
properties of polymer undergo a reversible phase change 
resulting in formation of a water insoluble, 
biodegradable gel depot. Oncogel is a frozen formulation 
of paclitaxel in Regel. It is a free flowing liquid below 
room temperature which upon injection forms a gel in-
situ in response to body temperature. hGHD-1 is a novel 
injectable depot formulation of human growth hormone 
(hGH) utilizing Macromed's Regel drug delivery system 
for treatment of patients with hGH deficiency.  
Cytoryn 
This is one of the Macromed's products, which is a 
novel, peritumoral, injectable depot formulation of 
interleukin-2 (IL-2) for cancer immunotherapy using 
Regel drug delivery system. It is a free flowing liquid 
below room temperature that instantly forms a gel depot 
upon injection from which the drug is released in a 
controlled manner. Cytoryn enhances the immunological 
response by safely delivering four times the maximum 
tolerated dose allowed by conventional IL-2 therapy. 
Cytoryn also activates the systemic antitumor immunity. 
Regel system stabilizes and releases IL-2 in its bioactive 
form. The release of drugs is controlled by the rate of 
diffusion from and degradation of the depot. 
Timoptic-XE 
It is a timolol maleate ophthalmic gel formulation of 
Merck and Co. Inc., supplied as a sterile, 
isotonic,buffered, aqueous gel forming solution of 
timolol maleate. This formulation is available in two 
dosage strengths 0.25% and 0.5% in market. The pH of 
the solution is approximately 7.0, and the osmolarity is 
260-330 mOsm. Each ml of Timoptic-XE 0.25% 
contains 2.5 mg of timolol (3.4 mg of timolol maleate). 
Inactive ingredients include gellan gum, tromethamine, 
mannitol, and water for injection and the preservative 
used is benzododecinium bromide 0.012%. Timoptic- 
XE, when applied topically on the eye, reduces the 
elevated, as well as normal intraocular pressure, whether 
or not accompanied by glaucoma.28 
CONCLUSION 
In conclusion, the primary requirement of a successful 
controlled release product focuses on increasing patient 
compliance which the in situ gel offers. Exploitation of 
polymeric in- situ gel for controlled release of various 
drugs provides a number of advantages over 
conventional dosage forms. Sustained and prolonged 
release of the drug, good stability and biocompatibility 
characteristics make the in situ gel dosage forms very 
reliable. Use of biodegradable and water soluble 
polymers for the in situ gel formulations can make them 
more acceptable and excellent drug delivery systems. 
The choice of a particular hydrogel depends on its 
intrinsic properties and investigated therapeutic use. For 
instance, the formation of a transparent gel is particularly 
important when ophthalmic application is considered. 
Non biodegradable gels could prove useful for 
administration routes other than parenteral. Polaxamer 
hydrogel perhaps stand for the most extensively studied 
systems. However, despite the clinical acceptance of 
poloxamer as solublizer and thickening agents, however, 
these systems may not be adapted for sustained release of 
hydrophilic, low molecular weight drugs because their 
large , water filled pores permit rapid diffusion . 
PEO/PLGA hydrogels are particularly attractive systems 
for pharmaceutical applications. 
Development of an efficient gastro retentive dosage form 
for stomach specific drug delivery is a real challenge. So, 
in order to produce the desired gastro retention various 
approaches have been employed, out of which, floating 
drug delivery system has emerged as most promising 
technique. Floating in situ gelling system is one of the 
approaches of floating drug delivery system which 
undergo sol to gel transition in acidic stomach conditions 
and provide stomach specific release of drug for longer 
duration while being buoyant on the gastric fluid surface.  
Such systems provide the advantage of better absorption 
of drugs which are absorbed from the upper part of 
stomach. As the system remains in the stomach for 
longer duration local action of drug due to prolonged 
contact time to gastric mucosa is increased. This leads to 
less frequent dosing and improved efficiency of 
treatment. By understanding the floating and gel forming 
behavior of polymers we can look forward to improve 
the gastric retention and hence bioavailability 
improvement of various pharmacologically active agents 
similarly, good stability and better drug release than 
other conventional dosage forms make such system more 
reliable. 
Dosage form with prolonged gastric retention and its 
compatibility with stomach physiology is the real 
challenge. So in order to achieve gastric retention various 
approaches have been done from several years. Out of 
which floating insitu drug delivery system is the most 
promising technique which undergo sol to gel transition 
in acidic medium of stomach and provide site specific 
release for longer duration of time by floating on the 
surface of gastric fluid, due to which its contact time 
with gastric mucosa is increased . This results in less 
frequent dosing and improves patient compliance. Insitu 
gels are not helpful for sustained drug delivery but also 
become convenient for pediatric and geriatric patients. 
Several biodegradable polymers are available with in situ 
gelling activity. By complete knowledge of floating 
behavior of biodegradable polymer we can look forward 
to improve gastric retention and hence bioavailability of 
pharmaceutical agents. In situ gel have good stability and 
biocompatibility  characteristics and better drug release 
which make it more reliable dosages from over the 
conventional one.30 
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